Novo Nordisk
Pharma

Novo snags FDA nod for oral obesity med with Wegovy in a pill

After ringing in a new era of obesity treatment with Wegovy, Novo Nordisk is making history again with the first GLP-1 pill for weight loss.
Fraiser Kansteiner Dec 22, 2025 6:59pm
Novo
Favicon Fierce Biotech

Novo vs. KBP Chapter 4: Lessons from the $1.3B fallout

Oct 2, 2025 3:00am
Johnson Johnsons Baby Powder

J&J will appeal $1.5B verdict in record-breaking talc award

Dec 23, 2025 11:06am
Pfizer

Pfizer confirms patient death in hemophilia drug trial

Dec 23, 2025 11:05am
dart board miss failure

Neurocrine's Ingrezza misses in cerebral palsy trial

Dec 23, 2025 10:20am
A paved road that reads 2025 that fades into the sunset

The stories that captivated our audience in 2025

Dec 23, 2025 10:15am
More News

Cytokinetics scores its first FDA nod with Myqorzo approval

Dec 22, 2025 12:05pm

BI's Jascayd quickly expands lung disease reach with new FDA nod

Dec 22, 2025 12:02pm
Fierce Healthcare

CMMI proposes new models to lower drug prices in Parts B, D

Dec 22, 2025 12:00pm

Colorectal cancer awareness campaign drives diagnosis in Nigeria

Dec 22, 2025 10:34am